Chapter 2. Cardiovascular Liabilities of Drugs: Regulatory Aspects

  1. Giorgio Minotti
  1. Claudio Arrigoni

Published Online: 9 APR 2010

DOI: 10.1002/9780470660379.ch2

Cardiotoxicity of Non-Cardiovascular Drugs

Cardiotoxicity of Non-Cardiovascular Drugs

How to Cite

Arrigoni, C. (2010) Cardiovascular Liabilities of Drugs: Regulatory Aspects, in Cardiotoxicity of Non-Cardiovascular Drugs (ed G. Minotti), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470660379.ch2

Editor Information

  1. University Campus Bio-Medico, CIR and Drug Sciences, and Alberto Sordi Foundation-Research Institute on Aging, Via Alvaro del Portillo 21, 00128 Rome, Italy

Author Information

  1. Accelera S.r.l., Viale Pasterur 10, P.O. box 11, 20014 Nerviano (MI), Italy

Publication History

  1. Published Online: 9 APR 2010
  2. Published Print: 16 APR 2010

ISBN Information

Print ISBN: 9780470772744

Online ISBN: 9780470660379

SEARCH

Keywords:

  • cardiovascular drugs liabilities - regulatory aspects;
  • cardiovascular safety pharmacology - regulatory aspects;
  • cardiovascular toxicology - regulatory aspects;
  • cardiovascular drugs effects -pharmacological and toxicological;
  • single drug administration - pharmacological adverse effects;
  • repeated drug administration - toxicological adverse effects

Summary

This chapter contains sections titled:

  • Introduction

  • Regulatory Aspects of Cardiovascular Safety Pharmacology

  • Regulatory Aspects of Cardiovascular Toxicology

  • Summary

  • References